Showing results 1 to 3 of 3
Issue Date | Title | Journal Title |
---|---|---|
2024 | Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial | NATURE COMMUNICATIONS |
2021 | Genomic landscape of extraordinary responses in metastatic breast cancer | COMMUNICATIONS BIOLOGY |
2021 | PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma | BMC CANCER |